...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Mutation Analysis of SLC26A4 for pendred syndrome and nonsyndromic hearing loss by high-resolution melting.
【24h】

Mutation Analysis of SLC26A4 for pendred syndrome and nonsyndromic hearing loss by high-resolution melting.

机译:SLC26A4突变分析,适用于复杂综合征和非综合征性听力损失。

获取原文
获取原文并翻译 | 示例

摘要

Pendred syndrome and DFNB4 (autosomal recessive nonsyndromic congenital deafness, locus 4) are associated with autosomal recessive congenital sensorineural hearing loss and mutations in the SLC26A4 gene. Extensive allelic heterogeneity, however, necessitates analysis of all exons and splice sites to identify mutations for individual patients. Although Sanger sequencing is the gold standard for mutation detection, screening methods supplemented with targeted sequencing can provide a cost-effective alternative. One such method, denaturing high-performance liquid chromatography, was developed for clinical mutation detection in SLC26A4. However, this method inherently cannot distinguish homozygous changes from wild-type sequences. High-resolution melting (HRM), on the other hand, can detect heterozygous and homozygous changes cost-effectively, without any post-PCR modifications. We developed a closed-tube HRM mutation detection method specific for SLC26A4 that can be used in the clinical diagnostic setting. Twenty-eight primer pairs were designed to cover all 21 SLC26A4 exons and splice junction sequences. Using the resulting amplicons, initial HRM analysis detected all 45 variants previously identified by sequencing. Subsequently, a 384-well plate format was designed for up to three patient samples per run. Blinded HRM testing on these plates of patient samples collected over 1 year in a clinical diagnostic laboratory accurately detected all variants identified by sequencing. In conclusion, HRM with targeted sequencing is a reliable, simple, and cost-effective method for SLC26A4 mutation screening and detection.
机译:Pendred综合征和DFNB4(常染色体隐性先天性非综合征性先天性耳聋,第4位)与SLC26A4基因常染色体隐性先天性感觉神经性听力损失和突变有关。然而,广泛的等位基因异质性需要对所有外显子和剪接位点进行分析,以鉴定单个患者的突变。尽管Sanger测序是进行突变检测的金标准,但结合靶向测序的筛选方法可以提供一种经济高效的选择。已开发出一种此类方法,即变性高效液相色谱法,用于SLC26A4中的临床突变检测。但是,该方法固有地不能将纯合变化与野生型序列区分开。另一方面,高分辨率熔解(HRM)可以经济高效地检测杂合和纯合变化,而无需进行任何PCR后修饰。我们开发了一种针对SLC26A4的闭合管HRM突变检测方法,可在临床诊断环境中使用。设计了28个引物对以覆盖所有21个SLC26A4外显子和剪接连接序列。使用产生的扩增子,初步的HRM分析检测到了先前通过测序鉴定的所有45种变体。随后,设计了一个384孔板,每次运行最多可采集三个患者样品。在临床诊断实验室中对这些样本进行了1年以上收集的患者样品的盲HRM测试可准确检测出所有通过测序鉴定的变体。总之,靶向测序的HRM是用于SLC26A4突变筛选和检测的可靠,简单且经济高效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号